drug · antibody
andecaliximab
Phase 3updated 3mo agoby Ashibio Inc🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 7 investigational indications.
targets
Matrix metalloproteinase-9
all catalysts(0)
nothing on the calendar yet
Trials studying andecaliximab
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 55m ago
Found something off?
comments(0)
5-min edit window · permanent after that